SEPSF (ASEP Medical Holdings) YoY EBITDA Growth: 72.09% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SEPSF ASEP Medical Holdings Inc SEPSF
16 GF Score
Price $0.01
! 4 Warning Signs
View Full Analysis

What is ASEP Medical Holdings YoY EBITDA Growth?

ASEP Medical Holdings SEPSF 16 YoY EBITDA Growth is 72.09% as of Mar. 2026. GuruFocus rates SEPSF with a GF Score™ of 16/100. The stock has 4 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. ASEP Medical Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 72.09%.

ASEP Medical Holdings's EBITDA per Share for the three months ended in Mar. 2026 was $-0.01.

ASEP Medical Holdings YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for ASEP Medical Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASEP Medical Holdings YoY EBITDA Growth Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
0.00 -108.36 -62.88 -17.56 58.78

ASEP Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.33 29.90 62.30 66.02 72.09
SEPSF
16GF Score
ASEP Medical Holdings Inc SEPSF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASEP Medical Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

ASEP Medical Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.472--1.145)/ | -1.145 |
=58.78 %

ASEP Medical Holdings's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(-0.012--0.043)/ | -0.043 |
=72.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 72.09% mean?
ASEP Medical Holdings (SEPSF) has a YoY EBITDA Growth of 72.09% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for ASEP Medical Holdings and its competitors.
Is ASEP Medical Holdings' YoY EBITDA Growth too high?
ASEP Medical Holdings' current YoY EBITDA Growth is 72.09%. Overall, ASEP Medical Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' YoY EBITDA Growth compare to VRTX and REGN?
ASEP Medical Holdings' YoY EBITDA Growth of 72.09% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Biotechnology company?
A good YoY EBITDA Growth depends on the Biotechnology industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for ASEP Medical Holdings and its competitors. ASEP Medical Holdings's current YoY EBITDA Growth is 72.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (SEPSF) has a current YoY EBITDA Growth of 72.09%. The current YoY EBITDA Growth is 72.09%. ASEP Medical Holdings' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For ASEP Medical Holdings (SEPSF), the current YoY EBITDA Growth is 72.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ASEP Medical Holdings Business Description

Other Exchanges JJ80:GermanyASEP:Canada
Address 4400 Chatterton Way, Unit 202, Victoria, BC, CAN, V8X 5J2
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
16GF Score

Get the complete analysis for SEPSF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price